The C-Type Lectin Receptor SIGNR3 Binds to Fungi Present in Commensal Microbiota and Influences Immune Regulation in Experimental Colitis by Magdalena Eriksson et al.
ORIGINAL RESEARCH ARTICLE
published: 16 July 2013
doi: 10.3389/fimmu.2013.00196
The C-type lectin receptor SIGNR3 binds to fungi present in
commensal microbiota and influences immune regulation
in experimental colitis
Magdalena Eriksson1,2,Timo Johannssen1,2, Dorthe von Smolinski 3, Achim D. Gruber 3, Peter H. Seeberger 1,2
and Bernd Lepenies1,2*
1 Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany
2 Department of Biology, Chemistry and Pharmacy, Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany
3 Department of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany
Edited by:
Paul A. Ramsland, Burnet Institute,
Australia
Reviewed by:
Irina Caminschi, Burnet Institute,
Australia
Thomas Jacobs,
Bernhard-Nocht-Institute for Tropical
Medicine, Germany
*Correspondence:
Bernd Lepenies, Institute of
Chemistry and Biochemistry, Max
Planck Institute of Colloids and
Interfaces, Arnimallee 22, Berlin
14195, Germany
e-mail: bernd.lepenies@
mpikg.mpg.de
Inflammatory bowel disease is a condition of acute and chronic inflammation of the gut. An
important factor contributing to pathogenesis is a dysregulated mucosal immunity against
commensal bacteria and fungi. Host pattern-recognition receptors (PRRs) sense commen-
sals in the gut and are involved in maintaining the balance between controlled responses to
pathogens and overwhelming innate immune activation. C-type lectin receptors (CLRs) are
PRRs recognizing glycan structures on pathogens and self-antigens. Here we examined
the role of the murine CLR specific intracellular adhesion molecule-3 grabbing non-integrin
homolog-related 3 (SIGNR3) in the recognition of commensals and its involvement in intesti-
nal immunity. SIGNR3 is the closest murine homolog of the human dendritic cell-specific
intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) receptor recognizing
similar carbohydrate ligands such as terminal fucose or high-mannose glycans. We dis-
covered that SIGNR3 recognizes fungi present in the commensal microbiota. To analyze
whether this interaction impacts the intestinal immunity against microbiota, the dextran sul-
fate sodium-induced colitis model was employed. SIGNR3−/− mice exhibited an increased
weight loss associated with more severe colitis symptoms compared to wild-type con-
trol mice. The increased inflammation in SIGNR3−/− mice was accompanied by a higher
level ofTNF-α in colon. Our findings demonstrate for the first time that SIGNR3 recognizes
intestinal fungi and has an immune regulatory role in colitis.
Keywords: SIGNR3, C-type lectin receptor, host innate immunity, colitis, carbohydrate recognition, microbiota,
fungi
INTRODUCTION
Inflammatory bowel disease (IBD) is a condition of acute and
chronic inflammation and can be classified in ulcerative colitis
(UC) and Crohn’s disease (CD). UC mainly affects the mucosal
lining of the colon and rectum, whereas inflammation in CD
occurs throughout the whole intestinal wall and may affect the
whole gastrointestinal tract (1). The mechanisms underlying these
severe diseases are poorly understood. However, epidemiologi-
cal and genetic studies in patients along with IBD-related animal
models suggest that a combination of genetic susceptibility, envi-
ronmental factors, and an altered immune response contribute
to pathogenesis (2). In particular, an imbalance of the mucosal
immunity against intestinal microbiota plays an essential role in
colitis induction (3, 4).
Abbreviations: CD, Crohn’s disease; CLR, C-type lectin receptor; DC, dendritic
cell; DCAR, dendritic cell immunoactivating receptor; DC-SIGN, dendritic cell-
specific intercellular adhesion molecule-3-grabbing non-integrin; hFc, human Fc;
IBD, inflammatory bowel disease; MBL, mannose binding lectin; MGL, macrophage
galactose-type lectin; NOD2, nucleotide oligomerization domain 2; PRR, pattern-
recognition receptor; SIGNR3, specific intracellular adhesion molecule-3 grabbing
non-integrin homolog-related 3; TLR, Toll like receptor; UC, ulcerative colitis.
While the role of T cells in gut inflammation has been stud-
ied in detail (5–7), there are limited insights in the involve-
ment of innate immunity in colitis. However, certain mediators
of innate immunity such as members of the TNFR superfam-
ily (8), co-stimulatory molecules (7, 9), or pattern-recognition
receptors (PRRs) (3, 10, 11) are involved in immune regula-
tion during colitis. The interaction of intestinal dendritic cells
(DCs) with commensals influences the fine balance between
tolerance and immune activation against commensals (12–14).
DCs recognize danger signals through PRRs that mediate bind-
ing and uptake of pathogens and initiate signaling pathways
(10, 15–17). Intestinal DCs from IBD patients express a higher
level of the DC activation marker CD40 than healthy controls
(18). In addition, the expression of certain PRRs, such as Toll
like receptors (TLRs), is upregulated on intestinal DCs in IBD
patients (18, 19). Recognition of microflora antigens and activa-
tion of TLRs are crucial for maintaining intestinal homeostasis
since mice lacking the adaptor protein MyD88 exhibit severe
weight loss along with epithelial damage upon colitis induction
(20, 21). Members of the Nucleotide oligomerization domain
(NOD)-like receptor family such as nucleotide oligomerization
domain 2 (NOD2) are involved in the intestinal immune response
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by regulating the initiation and progression of colitis (10, 11,
22, 23).
C-type lectin receptors (CLRs) are transmembrane PRRs rec-
ognizing carbohydrate structures present on pathogens or self-
antigens often in a Ca2+-dependent manner (16). The carbohy-
drate recognition specificities as well as the cytoplasmic signal-
ing motifs differ among the different CLR subfamilies (16, 24).
Recent studies indicate that CLRs are involved in gastrointestinal
inflammation and to date, four CLRs [Dectin-1, MGL1, mannose
binding lectin (MBL), and SIGNR1] have been shown to influ-
ence the development of murine colitis (25–28). The importance
of the CLR Dectin-1 in intestinal immunity was recently demon-
strated (28). Dectin-1 recognizes commensal fungi and mice lack-
ing Dectin-1 exhibited an increased susceptibility to chemically
induced colitis. A polymorphism in the human Dectin-1 gene
(CLEC7A) is associated with medically refractory UC indicating
the relevance of Dectin-1 for intestinal inflammation (28).
The human CLR dendritic cell-specific intercellular adhesion
molecule-3-grabbing non-integrin (DC-SIGN) specifically inter-
acts with fucose- and mannose-containing glycans (29, 30). Of the
eight murine homologs of DC-SIGN (31, 32), specific intracellu-
lar adhesion molecule-3 grabbing non-integrin homolog-related
3 (SIGNR3/CD209d) has the most similar biochemical character-
istics to the human receptor. Similar to DC-SIGN, SIGNR3 recog-
nizes terminal fucose,galactose, N -acetylgalactosamine residues as
well as fungal mannan structures (32–34). Mice lacking SIGNR3
are more susceptible to tuberculosis indicating the involvement of
SIGNR3 in early pulmonary resistance to M. tuberculosis (35). In
a recent study, SIGNR3 was reported to be involved in regulating
the cellular immune response to Leishmania infantum infection
via LTB4-dependent reduction of IL-1β production (36).
To date, the role of SIGNR3 in inflammation and autoimmunity
has not yet been elucidated. Thus, we analyzed the involvement of
SIGNR3 in the recognition of intestinal microbiota and its involve-
ment in intestinal inflammation. We show SIGNR3-dependent
binding to microbiota that can be inhibited by mannan. Fur-
ther analyses demonstrate that SIGNR3 binds indigenous fungi.
Consistently, SIGNR3−/− mice exhibited a higher susceptibility to
dextran sulfate sodium (DSS)-induced colitis as demonstrated by
increased weight loss and aggravated colitis symptoms compared
to wild-type mice. Exacerbation of DSS colitis in SIGNR3−/−
mice was accompanied by an increased TNF-α production in the
colon suggesting that fungal recognition by SIGNR3 contributes
to intestinal homeostasis. In conclusion, we show for the first time
that SIGNR3 recognizes fungi present in the intestinal microbiota,
thus plays an immune regulatory role in colitis.
MATERIALS AND METHODS
PRODUCTION AND CHARACTERIZATION OF CLR-hFc PROTEINS
C-type lectin receptors were expressed as soluble proteins fused to
the Fc part of human IgG1. The extracellular regions of the murine
SIGNR3, MGL1, and dendritic cell immunoactivating receptor
(DCAR) were amplified by PCR and ligated into the expres-
sion vector pFUSE-hIgG1-Fc2 (Invivogen, Toulouse, France;
Figure S1A in Supplementary Material). Proteins were transiently
expressed using the FreeStyle™ MAX CHO Expression System
(Life technologies, Darmstadt, Germany). Characterization and
functionality test of the SIGNR3-hFc protein was performed by
western blot analysis and ELISA (Figures S1A–D in Supplementary
Material).
BINDING STUDIES
To analyze the interaction of SIGNR3 with commensal microbes,
heat inactivated intestinal microbes were used. Fresh stool from
colon of C57BL/6 wild-type mice was inactivated at 65°C for 2 h
and diluted in PBS to an OD600 of 0.6. Microbiota were coated on
96-well high binding plates (Greiner, Frickenhausen, Germany)
overnight. After blocking with 1% BSA, 10µg/ml of SIGNR3-hFc,
DCAR-hFc, or hFc (Merck Millipore, Darmstadt, Germany) were
incubated in lectin binding buffer (50 mM HEPES, 5 mM MgCl2,
5 mM CaCl2, pH 7.4) or EDTA buffer (25 mM EDTA, 50 mM
HEPES, pH 7.4) at RT for 2 h. Washing steps were performed with
either lectin binding buffer or EDTA buffer. Coated zymosan incu-
bated with SIGNR3-hFc was used as a positive control. Binding
was detected by an alkaline phosphatase-conjugated goat anti-
hFc antibody (Dianova, Hamburg, Germany) and developed using
p-nitrophenyl phosphate (Thermo Scientific, Rockford, IL, USA).
To further characterize the microbial component recognized by
SIGNR3, stool microbes were labeled with SYTO® 61 red fluores-
cent nucleic acid stain (Life Technologies, Darmstadt, Germany)
at 2.5µM in PBS at RT for 30 min and washed three times in PBS.
Labeled microbiota were incubated with 1µg/ml CLR-hFc fusion
protein in lectin buffer supplemented with 0.5% BSA at 4°C for
1 h. After two additional washing steps, samples were incubated
with PE-conjugated goat anti-hFc antibody (Dianova). Carbohy-
drate specificity of the binding was analyzed by preincubation of
SIGNR3-hFc with mannan at a concentration of 0.01–10 mg/ml
at 4°C for 30 min. Commensal fungi were detected by staining
the samples with FITC-conjugated rabbit anti-C. albicans (Merid-
ian Life Science Inc., Memphis, TN, USA) at 4°C in the dark for
30 min. This antibody cross-reacts with other yeasts as described
by the manufacturer and as previously reported (28). Samples
were washed three times and analyzed using a FACSCanto II flow
cytometer (BD Pharmingen, Heidelberg, Germany). Data were
analyzed using FlowJo analysis software (Tree Star Inc., Ashland,
OR, USA).
CHEMICALLY INDUCED COLITIS
Mice were housed under special pathogen free (SPF) conditions
and were provided food and water ad libitum. The mouse strain
031934-UCD, SIGNR3 KO/Mmcd was provided by the NIH-
sponsored Mutant Mouse Regional Resource Center (MMRRC)
National System. Genotyping of the SIGNR3-gene in wild-type
and SIGNR3−/− mice was performed using a protocol provided
by the Consortium for Functional Glycomics (Figure S2 in Sup-
plementary Material). Colitis was induced in 8–11 week old female
SIGNR3-deficient mice or the respective wild-type C57BL/6 con-
trol mice by adding 3% DSS salt (reagent grade, 35–50 g/mol, MP
Biomedicals, Illkirch, France) to the drinking water for eight con-
secutive days. Body weight was recorded daily. On day seven, mice
were sacrificed and a disease activity index (DAI) was assigned to
each mouse (Table 1) as described previously (27), modified from
(37). Briefly, a score of 0–4 was assigned to each mouse depending
on stool consistency, presence of blood in feces, and weight loss.
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Table 1 | Scoring for disease activity index.
Score Blood in feces Stool consistency Weight loss (%)
0 No blood detected Normal 0
1 1–3
2 Blood detected Loose stool 3–6
3 6–9
4 Gross blood detected Diarrhea >9
Table 2 | Scoring system for histological evaluation of intestinal
lesions.
Score Infiltration of
inflammatory cells
Mucosal
erosion/ulceration
0 None None
1 Mild Mild
2 Moderate Moderate
3 Severe Severe
Blood in feces was detected with Greegor’s modified Guaiak test
(Haemoccult, Beckman Coulter, Galway, Ireland) according to the
manufacturer’s instructions.
Animal experiments were performed in strict accordance with
the German regulations of the Society for Laboratory Animal Sci-
ence (GV-SOLAS) and the European Health Law of the Federation
of Laboratory Animal Science Associations (FELASA). The proto-
col was approved by the Landesamt für Gesundheit und Soziales
(LAGeSo) Berlin (Permit Number: G0052/10). All efforts were
made to minimize suffering.
HISTOLOGY
Whole colon of each mouse was prepared as a Swiss roll in an
embedding cassette and immersion fixed with 4% buffered for-
malin. Samples were embedded in paraffin, sectioned at 4µm
thickness and stained with hematoxylin and eosin (H&E). Sections
were evaluated histopathologically in a blinded manner. Each
colon was divided into three segments of identical lengths and
each part was graded according to the degree of infiltration of
inflammatory cells and mucosal erosion/ulceration (Table 2).
COLON HOMOGENIZATION
Colon was homogenized using a modified Greenberger lysis buffer
containing 300 mM NaCl, 15 mM Tris, 2 mM MgCl2, 0.5% Tri-
ton X-100, Protease-inhibitor X, and Protease-inhibitor HP (Serva
Electrophoresis, Heidelberg, Germany) using an IKA T10 homog-
enizer (IKA-Werke GmbH, Staufen, Germany). Protein concentra-
tion was determined by the Pierce BCA Protein Assay Kit (Thermo
Scientific, Rockford, IL, USA) with BSA as a standard.
CYTOKINE MEASUREMENT
The measurement of cytokines in colon homogenate was per-
formed using cytometric bead array (BD Biosciences) as described
by the manufacturer. Analysis was performed with a FACSCanto II
flow cytometer (BD Biosciences) and the FCAP Array™ software
(BD Bioscience). The following cytokines were measured: IL-6,
IL-10, TNF-α, IL-12p70, and IL-1β.
STATISTICAL ANALYSIS
Statistical analyses were performed with the unpaired Student’s
t -test using the Prism program (GraphPad Software, La Jolla, CA,
USA). For analysis of the body weight, a mixed linear model was
used taking multiple measurements per mouse into account and
the structure of these measurements was assumed to be autore-
gressive. In addition to the parameter “group,” “day” was also a
parameter in the model. The analysis of the mixed linear model
was performed using SAS software version 9.3 (SAS Institute Inc.,
Cary, NC, USA). A p-value of p< 0.05 was considered statistically
significant.
RESULTS
SIGNR3 BINDS TO FUNGI PRESENT IN COMMENSAL MICROBIOTA
The CLR Dectin-1 recognizes commensal fungi and plays a cru-
cial role in intestinal immunity (28). To investigate whether
SIGNR3 contributes to the recognition of intestinal micro-
biota, we generated a SIGNR3-hFc fusion protein (Figure S1
in Supplementary Material) and determined binding of this
fusion protein to heat inactivated gut microbes using an ELISA-
based binding assay. Notably, a significantly higher interaction
of SIGNR3-hFc to intestinal microbiota was detected com-
pared with MGL1-hFc and DCAR-hFc produced in the same
way, or human Fc (hFc) alone, indicating specificity of the
SIGNR3-microbiota interaction. This interaction was almost
completely abolished when samples were incubated in the pres-
ence of 25 mM EDTA, indicating a Ca2+-dependent interaction
between SIGNR3 and intestinal microbiota (Figure 1A). Fur-
thermore, SIGNR3-hFc binding to microbiota was concentration-
dependent (data not shown). MGL1 was reported to bind Strep-
tococcus spp. and Lactobacillus spp. present in the gut micro-
biota (25). Noteworthy, the degree of interaction of SIGNR3-
hFc with commensal microbiota observed in this study even
exceeded that of MGL1-hFc, suggesting that SIGNR3 might
also be involved in intestinal recognition of microbes. In con-
trast, DCAR-hFc displayed only marginal interaction with stool
microbes.
To further examine the binding of SIGNR3 to the microbiota,
we characterized this interaction by flow cytometry. Fusion pro-
teins were incubated with stool microbes and detected using a
fluorescently labeled anti-hFc antibody. These binding studies
revealed that SIGNR3-hFc bound to about 8% of the microbes
(Figures 1B,C). Consistent with our results obtained by ELISA,
this interaction was significant compared with DCAR-hFc and
the specificity control hFc (Figure 1C). Furthermore, the inter-
action of SIGNR3-hFc and the microbes was blocked by man-
nan derived from S. cerevisiae in the concentration of 0.01–
10 mg/ml indicating specific carbohydrate recognition by SIGNR3
(Figure 1D).
To examine which subclass of microbes was recognized by
SIGNR3, co-staining with an antibody against C. albicans was per-
formed. This antibody cross-reacts with other yeasts as described
by the manufacturer and as previously reported (28) and stained
about 7% of the gut microbiota (Figure 1E). When microbiota
were co-stained with the anti-fungal antibody and SIGNR3-
hFc, >60% of fungi detected by the antibody were also stained
by SIGNR3-hFc (Figures 1E,F). In contrast, DCAR-hFc bound
www.frontiersin.org July 2013 | Volume 4 | Article 196 | 3
Eriksson et al. Commensal fungal recognition by SIGNR3
FIGURE 1 | Binding of SIGNR3 to fungi present in commensal
microbiota. (A) ELISA analysis of binding of CLR-hFc fusion proteins to
heat inactivated intestinal microbiota demonstrated significant binding of
SIGNR3-hFc. Binding of SIGNR3-hFc to zymosan, and MGL1-hFc to colon
microbiota were used as positive controls. If indicated, incubation and
washing was performed in 25 mM EDTA buffer to analyze
Ca2+-dependency of the interaction. Results are representative of three
independent experiments. (B) Representative dot plots of SytoRed stained
gut microbes (APC+) incubated with hFc, SIGNR3-hFc, or DCAR-hFc.
Detection with a PE-labeled goat anti-hFc antibody demonstrates binding
of SIGNR3-hFc to gut microbes. (C) Corresponding statistical analysis of
flow cytometry data representative from three independent experiments.
(D) The interaction of SIGNR3-hFc and microbes was inhibited by
preincubation with S. cerevisiae-derived mannan in the concentrations of
0.01–10 mg/ml. Data are representative of two independent experiments.
(E) Staining with a FITC-labeled anti-C. albicans antibody reported to
cross-react with other fungi revealed about 7% of the microbes were
fungi. Staining of cells with fusion proteins demonstrated that SIGNR3-hFc
recognizes >60% of the commensal fungi in the colon. (F) Statistical
analysis of commensal fungi detected by SIGNR3- and DCAR-hFc as
determined by flow cytometry. Shown are data and gating representative
for three independent experiments. (A–F) Data are presented as
mean+SEM. The p-values were determined using unpaired Student’s
t -test. **p<0.01, ***p<0.001, ****p<0.0001.
only marginally to fungi recognized by the anti-fungal antibody
(Figures 1E,F). This finding indicates that SIGNR3-hFc binds
specifically to a majority of intestinal fungi present in the murine
commensal microbiota.
SIGNR3 DEFICIENCY EXACERBATES DSS-INDUCED COLITIS
Since SIGNR3 binds to fungal populations in the gut, we hypoth-
esized that this interaction might play a role in intestinal immune
homeostasis as has been described for Dectin-1 (28). To test this
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hypothesis, DSS colitis was induced in SIGNR3−/− mice (for
genotyping, see Figure S2 in Supplementary Material) and the
respective wild-type control mice. Both wild-type and SIGNR3−/−
mice lost significantly weight from day 4 on and both strains
displayed marked colitis symptoms on day 7 (Figures 2A–D).
However, the weight loss at day 4–7 was significantly more pro-
nounced in DSS-treated SIGNR3−/− mice compared to wild-type
mice (Figure 2A). In addition, the DAI was markedly increased
in SIGNR3−/− mice (Figure 2B) indicating that SIGNR3 defi-
ciency led to an exacerbation of colitis. Blood was present in
stool of almost all mice from both strains treated with 3% DSS.
However, severe diarrhea (score 4) was present more often in
SIGNR3−/− mice than in wild-type mice resulting in a signif-
icantly increased stool score (Figure 2C). No such symptoms
or weight loss were present in untreated SIGNR3−/− mice or
untreated wild-type mice (data not shown). The colon was sig-
nificantly shorter in all mice treated with DSS compared to colon
from untreated wild-type mice (Figure 2D). No significant dif-
ference was observed between SIGNR3−/− mice and wild-type
mice though colon shortening tended to be more pronounced in
SIGNR3−/− mice.
Histological analysis of H&E stained colon tissue revealed a
severe, acute, multifocal to coalescent, partly transmural UC in
wild-type and SIGNR3−/− mice treated with DSS. Both groups
had severe submucosal edema and adjacent steatitis. However,
the percentage of altered tissue was increased in SIGNR3−/−
mice compared to wild-type mice (Figure 3A). Interestingly, tis-
sue damage and ulceration was exacerbated in SIGNR3−/− mice
both in the oral and rectal part of the colon, whereas the middle
part of the colon was equally affected in SIGNR3−/− and wild-
type mice (Figure 3B). Thus, histological evaluation confirmed
the higher susceptibility of SIGNR3−/− mice to DSS-induced
colitis.
SIGNR3 DEFICIENCY LEADS TO AN INCREASED TNF-α PRODUCTION
To address the mechanism that leads to the increased inflamma-
tion in SIGNR3−/− mice during DSS colitis, the local cytokine
response in the colon was analyzed. Pro-inflammatory cytokines
such as TNF-α, IL-1β, and IL-6 were detectable in both SIGNR3−/−
and wild-type mice upon induction of DSS colitis (Figure 4).
The concentrations of all tested cytokines were below the detec-
tion level in untreated wild-type (Figure 4) and SIGNR3−/−
mice (data not shown). Interestingly, the TNF-α level was signifi-
cantly higher in the colon of SIGNR3−/− mice during DSS colitis
(Figure 4A). To analyze whether the production of immune regu-
latory cytokines was affected by SIGNR3 deficiency, IL-10 levels in
colon homogenates were determined. However, levels were below
the detection level in both SIGNR3−/− and wild-type mice upon
colitis induction (data not shown) thus rendering a role of IL-10
unlikely. In conclusion, the lack of SIGNR3 binding to fungi is
accompanied by an increased TNF-α production, indicating a role
for SIGNR3 in intestinal immune homeostasis.
FIGURE 2 | Wild-type and SIGNR3−/− mice were fed 3% DSS
supplemented to the drinking water for seven consecutive days (n=31
for SIGNR3−/− mice, n=30 for wild-type mice). (A) Weight was recorded
daily. On day 7, disease activity index (B), stool score (C), and colon length (D)
were measured. SIGNR3−/− mice displayed an increased susceptibility to DSS
colitis as indicated by a more severe weight loss and exacerbated colitis
symptoms. A summary of four independent experiments is shown. Data are
expressed as mean+SEM. The p-values were determined using a mixed
linear model (A) and unpaired Student’s t -test (B–D). Significance is indicated
by asterisks (*), *p<0.05, **p<0.01, ***p<0.001.
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FIGURE 3 | After 7 days of DSS treatment, mice were sacrificed
and paraffin sections of the colon of each mouse were prepared
and stained with hematoxylin and eosin (H&E). A histopathological
evaluation of each section was performed in a blinded manner. (A)
H&E stained sections from colon of C57BL/6 wild-type, and SIGNR3−/−
mice at day 7, and untreated control mice. (B) Each colon was divided
into three segments of identical length (oral, middle, rectal) and each
segment of the colon was analyzed separately. The degree of
infiltration of inflammatory cells and mucosal erosion/ulceration was
graded from none (score 0) to mild (score 1), moderate (score 3), or
severe (score 4) (n=5). Data are expressed as mean+SEM. The
p-values were determined using unpaired Student’s t -test. Arrows
show examples of mucosal ulceration. Significance is indicated by
asterisks (*), *p<0.05.
FIGURE 4 | Cytokines in colon homogenates from wild-type
and SIGNR3−/− mice fed with 3% DSS were analyzed by
cytometric bead array. The levels of TNF-α (A), IL-6 (B), and IL-1β
(C) were measured (n=8 for DSS-treated SIGNR3−/− and
wild-type mice, n=5 for untreated wild-type mice). Data are
expressed as mean+SEM. The p-values were determined using
unpaired Student’s t -test. Significance is indicated by asterisks (*),
*p<0.05.
DISCUSSION
We report that SIGNR3 recognizes commensal fungi and is
involved in intestinal immune homeostasis during colon inflam-
mation. To date, SIGNR3 has been reported to bind to M.
tuberculosis (35) and C. albicans as well as the fungal cell
wall components zymosan and mannan (34). Consistently, the
binding of SIGNR3-hFc to commensal microbes was inhibited
by yeast-derived mannan. Mannan constitutes the outer cell wall
layer in nearly all fungi (38) and is recognized by several PRRs
such as TLR4, and the CLRs Mincle and Dectin-2, mediating
anti-fungal immune responses (39, 40). We thus postulated that
SIGNR3 might be involved in the recognition of intestinal fungi.
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Indeed, SIGNR3-hFc bound to the majority of present fungi as
illustrated by co-localization with an anti-fungal antibody. These
findings show that SIGNR3 recognizes fungi in the microbiota pre-
sumably by binding to mannose-rich structures. This recognition
of fungi is consistent with previous studies reporting recognition
of fungi-derived mannan, C. albicans (41, 42) and S. cerevisiae
(43) by human DC-SIGN. Activation of DC-SIGN by fungi leads
to activation of the raf-1 kinase, acetylation of NF-kB and thereby
an increase of TLR-induced IL-10 production (44). An increased
population of DC-SIGN+ DCs producing the cytokines IL-12 and
IL-18 was detected in colonic mucosa of patients with CD (45) sug-
gesting the involvement of this receptor in intestinal homeostasis.
This report together with the present study suggests that DC-SIGN
might be involved in the regulation of intestinal inflammation.
The discovered recognition of commensal fungi by SIGNR3
highlights that certain CLRs are involved in anti-fungal responses
in the gut. Binding of fungal mannan to Dectin-2, Mannose recep-
tor (MR), DC-SIGN, and Mincle, or the interaction of fungal β-
glucan with Dectin-1, induces intracellular signaling important for
anti-fungal immunity (40). For example, recognition of Malassezia
antigens by Dectin-1 and Mincle activates TNF-α and IL-10 pro-
duction (46, 47). To date, Dectin-1 is the only CLR reported
to bind to fungi present in the gut microbiota (28). Iliev et al.
showed that the direct interaction between commensal fungi and
the CLR Dectin-1 influences the intestinal immune response dur-
ing colitis (28). To analyze whether the interaction of SIGNR3 and
commensal fungi also influences the intestinal immune response,
we employed the DSS colitis model. This model has the advan-
tage that commensal microbes that are normally restricted to the
outer mucosal layer can penetrate the inner mucosal layer. As a
consequence, microbes interact with epithelial cells and are also
recognized by local immune cells which leads to the initiation of an
inflammatory response against the commensals (48, 49). Thus, this
model is suitable for analyzing the interplay of innate immunity
and the commensal microbiota (50). Indeed, after colitis induc-
tion, SIGNR3−/− mice exhibited a more severe weight loss and
exacerbated colitis symptoms such as severe diarrhea, cell infiltra-
tion into the colon, and mucosal ulceration compared to wild-type
mice, indicating an immune regulatory role of SIGNR3 in the gut.
Previous studies of mice lacking other PPRs, e.g., TLRs or
NOD-like receptors, which recognize microbial antigens, show
the involvement of PRRs in murine colitis (11, 20, 51). Alike the
SIGNR3−/− mice in our study, mice lacking NOD2 are more sus-
ceptible to colitis (23). Binding to the microbial ligand muramyl
dipeptide activates NF-kB signaling pathways (52). However, the
administration of NOD2 ligands to wild-type mice ameliorates
colitis symptoms (53) and NOD2 is involved in inducing a tolero-
genic environment by up-regulation of IL-10 expression and
proliferation of regulatory T cells (53).
Similar to our study, mice lacking Dectin-1 are more susceptible
to chemically induced colitis. This disease exacerbation is caused
by an altered immune response to fungal microbiota (28). The
portion of pathogenic fungal populations such as Candida and Tri-
chosporon is increased in Dectin-1−/−mice further demonstrating
the involvement of fungi and this CLR in the intestinal immune
regulation (28). Worse colitis symptoms along with increased anti-
fungal antibody titers were also found in MBL−/−mice suggesting
a role in the recognition of fungal commensals (26). Another
example of a CLR influencing the intestinal immunity is the
protective role of MGL1 in colitis demonstrated by more severe
inflammation in MGL1−/− mice during colitis (25). In contrast
to these studies, mice lacking SIGNR1 exhibited an ameliorated
form of murine colitis, with a reduction in the disease severity,
colon damage, and levels of the pro-inflammatory cytokines IL-
1β, TNF-α, and IL-6 (27). These reports together with the present
study demonstrate that certain CLRs influence the inflammatory
responses in murine colitis. We here report exacerbated symptoms
detected in SIGNR3−/− mice during colitis. Since certain myeloid
CLRs signal via common adaptors leading to Syk recruitment (24),
it is possible that the lack of SIGNR3 might be partially compen-
sated by other CLRs involved in the regulation of the intestinal
homeostasis. Thus, symptoms might even be more pronounced in
mice lacking multiple CLRs. However, the findings that one single
CLR has a marked influence on colitis pathogenesis points at an
indispensable role of SIGNR3 in murine colitis.
Upon colitis induction, a significantly increased level of TNF-α
was present in the colon of SIGNR3−/− mice compared to wild-
type mice. TNF-α plays a key role in IBD (54, 55) and adminis-
tration of TNF-α-neutralizing antibodies is an approved medical
therapy for IBD patients (56). Notably, mice lacking the CLR
Dectin-1 also display higher TNF-α levels in the colon after induc-
tion of colitis (28). Similar to Dectin-1, SIGNR3 has an intracel-
lular hemITAM and is suggested to signal via Syk and activation
of either of these CLRs is reported to induce TNF-α production
(24, 35). This increased TNF-α production in SIGNR3−/− mice
suggests that the recognition of commensal fungi by SIGNR3
is required for regulating homeostasis during intestinal inflam-
mation. This is similar to a very recent report on L. infantum
infection where DC-SIGN and SIGNR3 were reported to play a
regulatory role in L. infantum infection, and were suggested to be
important for the homeostasis in tissue areas with high microbial
content (36).
To date, a functional relevance of SIGNR3 has only been
described during M. tuberculosis infection (27). In the present
study, we show for the first time that SIGNR3 is involved in the
recognition of fungi present in the intestinal microbiota. Our
findings indicate that SIGNR3 is an important regulator of immu-
nity to fungal commensals in the colon, thus highlighting the
importance of this CLR in commensal recognition and mainte-
nance of intestinal immune homeostasis. Targeting of SIGNR3
or DC-SIGN might constitute a novel strategy to influence cellu-
lar responses to commensal fungi and thereby modulate chronic
intestinal inflammation (57).
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Figure S1 | Expression and functionality of recombinant SIGNR3-hFc. (A)
Expression cassette used for the production of SIGNR3-hFc. The cDNA
encoding for the extracellular part of SIGNR3 (SIGNR3 ECD) was amplified
using the following primers: SIGNR3 forward 5′-GAATTCCATGCAACTGAAG
GCTGAAG-3′ and SIGNR3 reverse 5′ AGATCTTTTGGTGGTGCATGATGA
GG-3′. The product was fused in frame to the Fc region of human IgG1.
Expression was driven by a hEF1-HTLV promoter and secretion into the culture
supernatant was mediated by an external IL2 signal sequence (IL2ss). (B)
Western blot analysis of recombinant SIGNR3-hFc. Marker (PageRuler Plus
Prestained Protein ladder, Thermo scientific) and 100 ng human Fc (hFc) or
SIGNR3-hFc were separated by SDS PAGE, transferred to a nitrocellulose
membrane, and detected using an HRP conjugated goat anti-hFc antibody. The
calculated molecular weight of the SIGNR3-Fc fusion protein is 44.7 kDa.
MGL1-hFc and DCAR-hFc were produced in the same way using target-specific
primers. (C,D) Binding of SIGNR3-hFc to immobilized mannan (C) or zymosan
(D). Coated microtiter plates were incubated with 10µg/ml hFc or SIGNR3-hFc.
Detection was performed using alkaline phosphatase-conjugated goat
anti-human-Fc antibody and p-nitrophenyl-phosphate. Data are expressed as
mean + SEM. The p-values were determined using unpaired Student’s t -test.
Significance is indicated by asterisks (∗), ∗∗∗p < 0.001.
Figure S2 | Genotyping of the SIGNR3-gene in wild-type and SIGNR3−/−
mice was performed with the following primers (sequences provided from
the Consortium for Functional Glycomics): SD.378 5′-TCCCCCTTCTGCCCT
TTTGG-3′, SD.375 5′-CCAATTCCCAGCTTCCACGG-3′, and SD.200 5′-GTTTG
GGGGAAATCCAGCTG-3′. Shown is the representative analysis of genomic DNA
of wild-type (+/+), heterozygous (+/−), and SIGNR3-deficient (−/−) mice.
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